Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06751303 | Patient Preferences for Precision Medicine: Determining Optimal Patient Quality of Life Using PARPi's(4PDQ) | recruiting | N/A | 100 | University of SaskatchewanOTHER | 1 | Dec 27, 2024 | clinicaltrials |
| NCT06640959 | Chronic Radiation Induced Bowel Toxicity Study(CRIBS) | recruiting | — | 50 | The Christie NHS Foundation TrustOTHER | 1 | Dec 20, 2024 |
| clinicaltrials |
| NCT06684327 | Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors | recruiting | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Dec 20, 2024 | clinicaltrials |
| NCT06696326 | A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate Cancer | recruiting | N/A | 100 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Dec 18, 2024 | clinicaltrials |
| NCT05989854 | The Remote Study: Investigating the Effects or Online Exercise on Quality of Life in Men With Prostate Cancer | recruiting | N/A | 50 | University of SurreyOTHER | 1 | Dec 17, 2024 | clinicaltrials |
| NCT05855941 | Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)(PRODIGYN) | recruiting | — | 120 | Region VästerbottenOTHER_GOV | 1 | Dec 16, 2024 | clinicaltrials |
| NCT06735326 | Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer | recruiting | Phase 2 | 105 | Qilu Hospital of Shandong UniversityOTHER | 1 | Dec 16, 2024 | clinicaltrials |
| NCT06736054 | A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer | recruiting | Phase 1 | 8 | Hoag Memorial Hospital PresbyterianOTHER | 1 | Dec 16, 2024 | clinicaltrials |
| NCT04113122 | Senescence and the Early Ageing Phenotype After Chemotherapy for Testicular Cancer: the SEA-CAT Study | recruiting | N/A | 192 | University Medical Center GroningenOTHER | 1 | Dec 13, 2024 | clinicaltrials |
| NCT05349227 | Comprehensive Outcomes for After Cancer Health(COACH) | recruiting | N/A | 625 | Pack HealthINDUSTRY | 1 | Dec 11, 2024 | clinicaltrials |
| NCT06726291 | Akynzeo as Antiemetic Treatment in Patients With Endometrial Cancer(NOEME) | recruiting | Phase 4 | 84 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Dec 10, 2024 | clinicaltrials |
| NCT06236373 | The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia(Survivorship) | recruiting | — | 45 | University of Modena and Reggio EmiliaOTHER | 1 | Dec 9, 2024 | clinicaltrials |
| NCT05655260 | PErsonalized TReatment for Endometrial Carcinoma(PETREC) | recruiting | N/A | 300 | University of HelsinkiOTHER | 1 | Dec 6, 2024 | clinicaltrials |
| NCT02573636 | The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients with Biochemical Failure Status Post Salvage or Radical Radiation Therapy | recruiting | — | 208 | Sir Mortimer B. Davis - Jewish General HospitalOTHER | 1 | Dec 4, 2024 | clinicaltrials |
| NCT04896801 | MR-guided Prostate Stereotactic Body Radiotherapy in Seven Days(Proseven) | recruiting | N/A | 132 | Universitair Ziekenhuis BrusselOTHER | 1 | Dec 4, 2024 | clinicaltrials |
| NCT05214937 | A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors | recruiting | N/A | 120 | University of TorontoOTHER | 1 | Dec 4, 2024 | clinicaltrials |
| NCT06278857 | SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)(SATELLITE) | recruiting | Phase 2 | 10 | Queensland Centre for Gynaecological CancerOTHER_GOV | 1 | Dec 3, 2024 | clinicaltrials |
| NCT06582628 | Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)(TEAM PC) | recruiting | Phase 2 | 78 | Fundacion OncosurNETWORK | 1 | Dec 2, 2024 | clinicaltrials |
| NCT06709326 | APACA-Apheresis/acoustophoresis and Molecular Characterization of Prostate Cancer | recruiting | N/A | 130 | Umeå UniversityOTHER | 1 | Nov 29, 2024 | clinicaltrials |
| NCT06437353 | Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer | recruiting | Phase 2 | 74 | Anhui Provincial Cancer HospitalOTHER | 1 | Nov 27, 2024 | clinicaltrials |
| NCT06706921 | 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer | recruiting | Phase 4 | 15 | VA Greater Los Angeles Healthcare SystemFED | 1 | Nov 27, 2024 | clinicaltrials |
| NCT06603506 | Collection of Endometrial Cancer-derived Organoids to Evaluate the Efficacy of PARP Inhibitors: PENDOR Pilot Study(PENDOR) | recruiting | — | 16 | Centre Francois BaclesseOTHER | 1 | Nov 26, 2024 | clinicaltrials |
| NCT05824975 | A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) | recruiting | Phase 1 / Phase 2 | 358 | GI Innovation, Inc.INDUSTRY | 2 | Nov 25, 2024 | clinicaltrials |
| NCT05927818 | Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer | recruiting | N/A | 100 | Istanbul UniversityOTHER | 1 | Nov 25, 2024 | clinicaltrials |
| NCT06692166 | A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer | recruiting | Phase 3 | 420 | Mabwell (Shanghai) Bioscience Co., Ltd.INDUSTRY | 1 | Nov 22, 2024 | clinicaltrials |
| NCT02754115 | An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy | recruiting | — | 400 | Tata Memorial CentreOTHER | 1 | Nov 21, 2024 | clinicaltrials |
| NCT05933876 | The Impact of Radiotherapy on Oligometastatic Cancer | recruiting | — | 2,000 | Institut Investigacio Sanitaria Pere VirgiliOTHER | 1 | Nov 18, 2024 | clinicaltrials |
| NCT05656573 | CART-PSMA Cells for Advanced Prostate Cancer | recruiting | Phase 1 | 20 | Nova Therapeutics LLCINDUSTRY | 1 | Nov 15, 2024 | clinicaltrials |
| NCT05694208 | The Effect of Mobile-Based Education Given to Patients Undergoing Gynecological Oncology Surgery on Quality of Life | recruiting | N/A | 84 | Istanbul University - CerrahpasaOTHER | 1 | Nov 15, 2024 | clinicaltrials |
| NCT06027892 | Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer(SABR-Dual) | recruiting | N/A | 562 | Rabin Medical CenterOTHER | 1 | Nov 15, 2024 | clinicaltrials |
| NCT06686043 | HPV Vaccine, Imiquimod, and Metformin Combination Trial(HPV-VIM) | recruiting | Phase 2 | 85 | Baylor College of MedicineOTHER | 1 | Nov 13, 2024 | clinicaltrials |
| NCT06665932 | Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins | recruiting | N/A | 100 | University Hospital OstravaOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT06683066 | Study on Human Bioequivalence of Triprerelin Acetate for Injection | recruiting | Phase 1 | 120 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT06685562 | The 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in Oncology | recruiting | — | 500 | Leiden University Medical CenterOTHER | 3 | Nov 12, 2024 | clinicaltrials |
| NCT06680791 | Molecular Classification in Relation to Prevention of Endometrial Cancer Recurrence and Lifestyle Factors(MPEC) | recruiting | — | 280 | Lukas VanekOTHER_GOV | 1 | Nov 8, 2024 | clinicaltrials |
| NCT05001477 | Customized TULSA-PRO Ablation Registry(CARE) | recruiting | — | 1,000 | Profound Medical Inc.OTHER | 1 | Nov 6, 2024 | clinicaltrials |
| NCT06579417 | ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer(ART-Pro) | recruiting | — | 500 | University of California, San DiegoOTHER | 2 | Nov 6, 2024 | clinicaltrials |
| NCT06289062 | Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer | recruiting | Phase 2 | 40 | Tongji HospitalOTHER | 1 | Nov 5, 2024 | clinicaltrials |
| NCT06672497 | Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients | recruiting | — | 30 | University of South CarolinaOTHER | 1 | Nov 4, 2024 | clinicaltrials |
| NCT06288373 | Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC | recruiting | Phase 2 / Phase 3 | 440 | Tongji HospitalOTHER | 1 | Oct 30, 2024 | clinicaltrials |
| NCT05403554 | A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers | recruiting | Phase 1 | 70 | Light Chain Bioscience - Novimmune SAINDUSTRY | 2 | Oct 29, 2024 | clinicaltrials |
| NCT06416748 | Minimally Invasive Simple Hysterectomy in Low Risk Cervical Cancer(LASH) | recruiting | N/A | 974 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Oct 29, 2024 | clinicaltrials |
| NCT06663007 | RC48 Monotherapy or Combination With Envafolimab for CDK12 Alterations mCRPC With Standard Treatment Failure | recruiting | Phase 1 / Phase 2 | 72 | Tianjin Medical University Second HospitalOTHER | 1 | Oct 29, 2024 | clinicaltrials |
| NCT06416150 | Reducing Urban Cervical Cancer Disparities | recruiting | N/A | 546 | Fox Chase Cancer CenterOTHER | 1 | Oct 26, 2024 | clinicaltrials |
| NCT06584279 | Diagnostic Value of MRI-targeted Plus Index-lesion-ipsilaterally Systematic Biopsy for Biopsy-naive Men At Risk of Prostate Cancer | recruiting | — | 563 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Oct 24, 2024 | clinicaltrials |
| NCT06617481 | PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence | recruiting | Phase 2 | 30 | AdventHealthOTHER | 1 | Oct 24, 2024 | clinicaltrials |
| NCT06656949 | Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer(SLN-EC-01) | recruiting | N/A | 42 | Qilu Hospital of Shandong UniversityOTHER | 1 | Oct 24, 2024 | clinicaltrials |
| NCT06614790 | Niraparib Maintenance Treatment in Patients With Newly Diagnosed Advanced Platinum- Sensitive, OC. The First Poland RWE Study.(NIRAPARIB) | recruiting | — | 300 | Pomeranian Medical University SzczecinOTHER | 1 | Oct 23, 2024 | clinicaltrials |
| NCT06655259 | Combination of TURP and Standard Systemic Therapy for MPCa(CTUSMEP01) | recruiting | Phase 2 | 200 | Fudan UniversityOTHER | 1 | Oct 23, 2024 | clinicaltrials |
| NCT06655506 | Enhanced Recovery Protocols in Gynecologic Oncology(ERGO) | recruiting | — | 600 | National and Kapodistrian University of AthensOTHER | 1 | Oct 23, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Dec 27, 2024source: clinicaltrials